018612845

EliVax

---

December 1, 2021

Trademark Summary

The trademark application EliVax was filed by Elixirgen Therapeutics, Inc, a U.S. corporation (the "Applicant"). The application was published for oppositions on January 11, 2022, and it was registered by office on April 20, 2022 without any oppositions.

The application was filed in Dutch (English was selected as the second language).

Change of name and professional address of the trademark registration was recorded on September 19, 2023.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Vaccines for human use
  2. Vaccine for animals
  3. Drug and vaccine for the cancer treatment
  4. Vaccine adjuvants.
• The mark was filed in class 42 with Research and development of vaccines and medicines.
• The mark was filed in class 44 with Inoculation of the vaccine.